SFM

Sphera Funds Management Portfolio holdings

AUM $382M
This Quarter Return
-5.65%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$417M
AUM Growth
+$417M
Cap. Flow
-$5.3M
Cap. Flow %
-1.27%
Top 10 Hldgs %
35.02%
Holding
95
New
14
Increased
26
Reduced
18
Closed
15

Top Buys

1
TSEM icon
Tower Semiconductor
TSEM
$7.42M
2
CYTK icon
Cytokinetics
CYTK
$6.89M
3
AMD icon
Advanced Micro Devices
AMD
$4.97M
4
META icon
Meta Platforms (Facebook)
META
$4.57M
5
INBX
Inhibrx, Inc. Common Stock
INBX
$3.79M

Top Sells

1
NICE icon
Nice
NICE
$8.5M
2
NVMI icon
Nova
NVMI
$8.21M
3
CAMT icon
Camtek
CAMT
$6.75M
4
PRAX icon
Praxis Precision Medicines
PRAX
$6.69M
5
SAGE
Sage Therapeutics
SAGE
$6.02M

Sector Composition

1 Healthcare 79.93%
2 Technology 10.32%
3 Consumer Discretionary 2.91%
4 Communication Services 1.1%
5 Materials 0.63%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PNT
26
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$6.35M 1.16%
952,642
– –
TEVA icon
27
Teva Pharmaceuticals
TEVA
$21.5B
$6.12M 1.11%
600,000
-450,000
-43% -$4.59M
NVS icon
28
Novartis
NVS
$248B
$6.11M 1.11%
60,000
– –
SRPT icon
29
Sarepta Therapeutics
SRPT
$1.98B
$6.06M 1.1%
50,000
– –
MRUS icon
30
Merus
MRUS
$5.04B
$5.97M 1.09%
253,333
-25,000
-9% -$590K
IRON icon
31
Disc Medicine
IRON
$2.14B
$5.23M 0.95%
111,398
-59,180
-35% -$2.78M
INZY
32
DELISTED
Inozyme Pharma
INZY
$5.19M 0.94%
1,234,907
+102,940
+9% +$432K
AMD icon
33
Advanced Micro Devices
AMD
$263B
$4.97M 0.91%
+48,320
New +$4.97M
CLDX icon
34
Celldex Therapeutics
CLDX
$1.57B
$4.95M 0.9%
180,000
+20,000
+13% +$550K
ETNB icon
35
89bio
ETNB
$1.37B
$4.93M 0.9%
319,301
+184,301
+137% +$2.85M
PTCT icon
36
PTC Therapeutics
PTCT
$4.41B
$4.9M 0.89%
218,459
+118,359
+118% +$2.65M
INBX
37
DELISTED
Inhibrx, Inc. Common Stock
INBX
$4.7M 0.86%
256,371
+206,371
+413% +$3.79M
META icon
38
Meta Platforms (Facebook)
META
$1.85T
$4.57M 0.83%
+15,220
New +$4.57M
GRCL
39
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$4.41M 0.8%
1,531,497
+302,832
+25% +$872K
ATXS icon
40
Astria Therapeutics
ATXS
$394M
$4.33M 0.79%
580,599
+109,581
+23% +$817K
MLYS icon
41
Mineralys Therapeutics
MLYS
$1.94B
$4.33M 0.79%
455,400
+50,000
+12% +$476K
RCKT icon
42
Rocket Pharmaceuticals
RCKT
$358M
$4.28M 0.78%
209,040
-26,960
-11% -$552K
COGT icon
43
Cogent Biosciences
COGT
$1.83B
$4.1M 0.75%
420,000
– –
JSPR icon
44
Jasper Therapeutics
JSPR
$44.2M
$3.98M 0.73%
5,687,134
+1,413,126
+33% +$989K
PMN icon
45
ProMIS Neurosciences
PMN
$23.7M
$3.69M 0.67%
+1,834,042
New +$3.69M
XBI icon
46
SPDR S&P Biotech ETF
XBI
$5.29B
$3.65M 0.67%
50,000
– –
GSK icon
47
GSK
GSK
$79.3B
$3.63M 0.66%
100,000
– –
MIRM icon
48
Mirum Pharmaceuticals
MIRM
$3.75B
$3.61M 0.66%
+114,284
New +$3.61M
AMLX icon
49
Amylyx Pharmaceuticals
AMLX
$877M
$3.55M 0.65%
193,650
+93,650
+94% +$1.71M
FUSN
50
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$3.52M 0.64%
1,354,258
+25,000
+2% +$65K
1
2
3 4